Intervention not reported
Time to resolution of clinical signs and symptoms [days] · adults and children with clinical signs and symptoms of acute lower respiratory tract infection
1 finding from 1 review
Number of days for persistent drainageSMD · people with breast and axillary surgery
1 finding from 1 review
Asthma control · Children and adults with persistent asthma.
Intermittent 'as needed' ICS showed no clear difference in proportion of asthma control days over the period (duration 44 to 52… compared with daily ICS (moderate certainty).
1 finding from 1 review
Change from baseline mean daily use of β2‐agonists (puffs/day) (duration 24 to 44 weeks) · Children and adults with persistent asthma.
Intermittent 'as needed' ICS showed no clear difference in change from baseline mean daily use of β2‐agonists (puffs/day)… compared with daily ICS (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of bad physical health days in past 30 days · working‐age adults
It is very uncertain whether the intervention changes number of bad physical health days in past 30 days (very low certainty).
1 finding from 1 review
Intervention not reported
Mental health/psychological distress Number of bad mental health days in past 30 days · working‐age adults
It is very uncertain whether the intervention changes mental health/psychological distress Number of bad mental health… (very low certainty).
1 finding from 1 review
Intervention not reported
One day of piperacillin, cefazolin, cefmetazole, or cefotiam versus three days of piperacillin, cefazolin, cefmetazole, or cefotiam (elective colorectal surgery) · surgical patients
It is very uncertain whether the intervention changes one day of piperacillin, cefazolin, cefmetazole, or cefotiam versus… (very low certainty).
1 finding from 1 review
Intervention not reported
One day of piperacillin, cefazolin, cefmetazole, or cefotiam versus three days of piperacillin, cefazolin, cefmetazole, or cefotiam (elective colorectal surgery) · surgical patients
1 finding from 1 review
Global state: 2. Requiring 3 or more injections ‐ over 7 days · patients with acute schizophrenia and similar serious mental illnesses
ZUCLOPENTHIXOL ACETATE may leads to lower global state: 2. Requiring 3 or more injections ‐ over 7 days compared with STANDARD DRUG CARE (low certainty).
1 finding from 1 review
Global state: 2. Requiring 3 or more injections ‐ over 7 days · patients with acute schizophrenia and similar serious mental illnesses
1 finding from 1 review
Duration of diarrhoea · patients symptomatic for NTS infection
1 finding from 1 review
Fever clearance time · patients symptomatic for NTS infection
1 finding from 1 review
Duration of illness · patients symptomatic for NTS infection
1 finding from 1 review
Diarrhoea · patients symptomatic for NTS infection
It is very uncertain whether antibiotics changes presence of diarrhoea at 2‐4 days compared with placebo or no treatment (very low certainty).
2 findings from 1 review
Intervention not reported
rhIGF‐I, 0.1 mg/kg/day ‐ survival at12 months · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
Intervention not reported
rhIGF‐I, 0.1 mg/kg/day ‐ change in AALSRS at 9 months · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
Intervention not reported
rhIGF‐I, 0.1 mg/kg/day ‐ change in SIP after 9 months · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
no estimate extracted
156 participants
Low
Asthma relapse1at 20 to 24 days · predominantly adults with acute asthma following emergency department discharge
Any ICS plus oral corticosteroid showed no clear difference in asthma relapse1at 20 to 24 days compared with oral corticosteroid (high certainty).
1 finding from 1 review
Hoarseness at 20 to 24 days · predominantly adults with acute asthma following emergency department discharge
Any ICS plus oral corticosteroid showed no clear difference in hoarseness at 20 to 24 days compared with oral corticosteroid (moderate certainty).
1 finding from 1 review
Asthma relapse1at 16 to 21 days · patients with acute asthma following emergency department discharge
Any ICS showed no clear difference in asthma relapse1at 16 to 21 days compared with oral corticosteroid (moderate certainty).
1 finding from 1 review